Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis

Patient‐reported quality‐of‐life (QoL) and carer impacts are not reported after leucine‐rich glioma‐inactivated 1‐antibody encephalitis (LGI1‐Ab‐E). From 60 patients, 85% (51 out of 60) showed one abnormal score across QoL assessments and 11 multimodal validated questionnaires. Compared to the premo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of Clinical and Translational Neurology 2024-04, Vol.11 (4), p.1053-1058
Hauptverfasser:	Binks, Sophie N. M., Veldsman, Michele, Handel, Adam E., Jacob, Saiju, Maddison, Paul, Coebergh, Jan, Michael, Sophia, Ramanathan, Sudarshini, Easton, Ava, Nissen, Mette Scheller, Leite, Maria Isabel, Okai, David, Blaabjerg, Morten, Husain, Masud, Irani, Sarosh R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Autoantibodies Brief Communication Comparative analysis Encephalitis Fatigue - etiology Glioma Humans Intracellular Signaling Peptides and Proteins Leucine Quality of Life Surveys Viral antibodies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Patient‐reported quality‐of‐life (QoL) and carer impacts are not reported after leucine‐rich glioma‐inactivated 1‐antibody encephalitis (LGI1‐Ab‐E). From 60 patients, 85% (51 out of 60) showed one abnormal score across QoL assessments and 11 multimodal validated questionnaires. Compared to the premorbid state, QoL significantly deteriorated (p
ISSN:	2328-9503 2328-9503
DOI:	10.1002/acn3.52006